Search alternatives:
significant challenges » significant challenge (Expand Search), significant changes (Expand Search), significant change (Expand Search)
point decrease » point increase (Expand Search)
mean decrease » a decrease (Expand Search)
Showing 21 - 40 results of 22,327 for search '(( significant challenges faced ) OR ( significant ((point decrease) OR (mean decrease)) ))', query time: 1.51s Refine Results
  1. 21
    Task variability/correlations decrease independently of mean task activity removal step in fMRI data.

    Task variability/correlations decrease independently of mean task activity removal step in fMRI data. by Takuya Ito (57473)

    Published 2020
    Save to List
    Saved in:
  2. 22
    HRV parameters at different time points.

    HRV parameters at different time points. by Shiying Liu (1569478)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  3. 23
    Challenges faced by treatment clients and their relapse risk during the lockdown and reopening, respectively.

    Challenges faced by treatment clients and their relapse risk during the lockdown and reopening, respectively. by Zhongyang He (19666925)

    Published 2024
    Save to List
    Saved in:
  4. 24
    PAP I point mutations lead to a decrease in pYV PCN, plasmid stability, and T3SS activity.

    PAP I point mutations lead to a decrease in pYV PCN, plasmid stability, and T3SS activity. by Katherine Schubert (5452712)

    Published 2025
    Save to List
    Saved in:
  5. 25
    Divergence from transmitted/founder (TF) virus increases during ART-naïve infection and decreases on treatment.

    Divergence from transmitted/founder (TF) virus increases during ART-naïve infection and decreases on treatment. by Kelsie Brooks (8928044)

    Published 2020
    Save to List
    Saved in:
  6. 26
    Challenges faced at the professional level and hospital type (only yes value is included).

    Challenges faced at the professional level and hospital type (only yes value is included). by Mastura Kashmeeri (19746371)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  7. 27
    Summary of post-treatment disease course measures from MDMA-AT publications.

    Summary of post-treatment disease course measures from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 28
    Study selection criteria.

    Study selection criteria. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 29
    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.

    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 30
    Disease course measures after the PTSD treatments.

    Disease course measures after the PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 31
    PICOS criteria for the SLR.

    PICOS criteria for the SLR. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 32
    Summary of post-treatment CAPS score changes from MDMA-AT publications.

    Summary of post-treatment CAPS score changes from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 33
    Summary of post-treatment disease course measures from off-label medications clinical trials.

    Summary of post-treatment disease course measures from off-label medications clinical trials. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 34
    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.

    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 35
    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.

    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 36
    Summary of post-treatment disease course measures from clinical trials with psychotherapies.

    Summary of post-treatment disease course measures from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 37
    PRISMA flow chart.

    PRISMA flow chart. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 38
    Summary of clinical efficacy of relevant PTSD treatments.

    Summary of clinical efficacy of relevant PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 39
    Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.

    Post-treatment CAPS score changes from clinical trials with off-label PTSD medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 40
    Descriptive statistics for the cultural challenges faced by refugee children residing in Saudi Arabia and Turkey.

    Descriptive statistics for the cultural challenges faced by refugee children residing in Saudi Arabia and Turkey. by Thoraya A. bin Kadasah (22647886)

    Published 2025
    Save to List
    Saved in:

Search Tools: